| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/05/2023 | 253.26% | Ladenburg Thalmann | → $3.25 | Initiates Coverage On | → Buy |
What is the target price for Sonoma Pharmaceuticals (SNOA)?
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Ladenburg Thalmann on September 5, 2023. The analyst firm set a price target for $3.25 expecting SNOA to rise to within 12 months (a possible 253.26% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sonoma Pharmaceuticals (SNOA)?
The latest analyst rating for Sonoma Pharmaceuticals (NASDAQ: SNOA) was provided by Ladenburg Thalmann, and Sonoma Pharmaceuticals initiated their buy rating.
When is the next analyst rating going to be posted or updated for Sonoma Pharmaceuticals (SNOA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sonoma Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sonoma Pharmaceuticals was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
Is the Analyst Rating Sonoma Pharmaceuticals (SNOA) correct?
While ratings are subjective and will change, the latest Sonoma Pharmaceuticals (SNOA) rating was a initiated with a price target of $0.00 to $3.25. The current price Sonoma Pharmaceuticals (SNOA) is trading at is $0.92, which is within the analyst's predicted range.